# To Evaluate the Safety and Effectiveness of Flow Modulation Device for Intracranial Aneurysms

Study · id `cardio:ct-nct06158750` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06158750](<https://clinicaltrials.gov/study/NCT06158750>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT06158750

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

## Technical summary

Registry record NCT06158750. Allocation not applicable; no masking; primary purpose treatment. Start 2023-11-17 (actual); primary completion 2026-02-28 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT06158750, source copy `cardio:ctgov-nct06158750-2024-06-27`, retrieved 2026-11-18)
- Started: 2023-11-17 (actual) (ClinicalTrials.gov record NCT06158750, source copy `cardio:ctgov-nct06158750-2024-06-27`, retrieved 2026-11-18)
- Primary completion: 2026-02-28 (anticipated) (ClinicalTrials.gov record NCT06158750, source copy `cardio:ctgov-nct06158750-2024-06-27`, retrieved 2026-11-18)
- Completion: 2026-06-30 (anticipated) (ClinicalTrials.gov record NCT06158750, source copy `cardio:ctgov-nct06158750-2024-06-27`, retrieved 2026-11-18)
- Countries: China (ClinicalTrials.gov record NCT06158750, source copy `cardio:ctgov-nct06158750-2024-06-27`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06158750-2024-06-27`, retrieved 2026-11-18)

## The registry's words

- Brief title: To Evaluate the Safety and Effectiveness of Flow Modulation Device for Intracranial Aneurysms
- Condition: Intracranial Aneurysm
- Intervention (Device): p64/p48 MW HPC Flow Modulation Device
- Lead sponsor: Shanghai Wallaby Medical Technologies Co.,Inc.
- Lead sponsor class: INDUSTRY
- Collaborator: Phenox GmbH
- Collaborator class: INDUSTRY
- Collaborator: Beijing Wallaby Medical Technologies Co.,Inc.
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Brain aneurysm (intracranial aneurysm) (`cardio:intracranial-aneurysm`)
- Registry lists this organization as a collaborator: Phenox GmbH (`cardio:org-phenox-gmbh`)

## Provenance

Content hash: 761b5a35dff384bf16f46267b8e5bb1237aeff3bb6573cd6ff387d41bb974c6f
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
